AF0144,
Imagent BP,
Imagent GI,
L 1913,
L-1913,
LA 11063,
LA11063,
Oxygent,
perflubron,
perflubron emulsion,
perfluoroctylbromide,
perfluorooctyl bromide,
perfluorooctyl iodide,
perfluorooctylbromide,
perfluorooctyliodide,
PFOB,
1-Bromoperfluorooctane,
423-55-2,
Perflubron,
Perfluorooctyl bromide,
1-Bromoheptadecafluorooctane,
Oxygent,
Perfluoro-n-octyl Bromide,
Imagent GI,
Perfluorooctylbromide,
LiquiVent,
Perfluoroctyl bromide,
PFOB,
Long's compound,
IMAGENT,
C8BrF17,
Bromoperfluoroctane,
UNII-Q1D0Q7R4D9,
Heptadecafluoro-n-octyl Bromide,
EINECS 207-028-4,
1-bromo-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane,
Q1D0Q7R4D9,
CHEBI:38803,
WTWWXOGTJWMJHI-UHFFFAOYSA-N,
MFCD00042082,
OCTANE, 1-BROMOHEPTADECAFLUORO-,
NCGC00166217-01,
oxygent ca,
Octane, 1-bromo-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-,
DSSTox_CID_26560,
DSSTox_RID_81719,
DSSTox_GSID_46560,
Perfluorooctyl bromide, 99%,
Imagent BP,
perflubron emulsion,
perfluoroctylbromide,
CAS-423-55-2,
Perflubron [USAN:INN],
Perflubron [USAN:USP:INN],
Imagent (TN),
perfluoro-octylbromide,
LA11063,
LA 11063,
Perflubron (USP/INN),
AC1Q4HRA,
ACMC-1AP0C,
Heptadecafluorooctyl bromide,
L 1913,
AC1L1U0J,
bromure de n-perfluorooctyle,
SCHEMBL33826,
CHEMBL1200866,
DTXSID5046560,
CF3-(CF2)6-CF2-Br,
CTK3J2391,
1-Bromoheptadecafluorooctane, 99%,
KS-000001AW,
ZINC8214650,
ZX-AP003882,
Tox21_112353,
3113AE,
ANW-29799,
AKOS015833872,
Tox21_112353_1,
DB05791,
DIMYRISTOYL LECITHIN; PERFLEXANE,
FS-4333,
RTR-033009,
TRA0002114,
NCGC00166217-02,
AN-44840,
CC-04278,
LS-97848,
SC-78379,
AB1011042,
DB-050901,
TR-033009,
FT-0607546,
D05439,
K-8801,
C-22932,
SR-01000944517,
SR-01000944517-1,
I14-25871,
Perflubron, United States Pharmacopeia (USP) Reference Standard,
1-bromo-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-octane,
bromoperfluorooctane,
perfluorooctyliodide,
Perfluorooctyl iodide,
D02XBE,
C8-Br-F17,
CID9873,
AF0144,
AR-1K9529,
L-1913,
1-Bromoheptadecafluorooctane, 99% - 1G 1g,
H0946,
Perflubron emulsion (blood substitute), Alliance,
C003072,
7044-91-9,